Your browser doesn't support javascript.
loading
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
Lonati, Chiara; Mordasini, Livio; Afferi, Luca; De Cobelli, Ottavio; Di Trapani, Ettore; Necchi, Andrea; Colombo, Renzo; Briganti, Alberto; Montorsi, Francesco; Simeone, Claudio; Zamboni, Stefania; Simone, Giuseppe; Karnes, Robert Jeffrey; Marra, Giancarlo; Soria, Francesco; Gontero, Paolo; Shariat, Shahrokh F; Pradere, Benjamin; Hendricksen, Kees; Ammiwala, Maida; Rink, Michael; Poyet, Cédric; Krajewski, Wojciech; Baumeister, Philipp; Mattei, Agostino; Moschini, Marco; Carando, Roberto.
Afiliação
  • Lonati C; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Urology, Spedali Civili di Brescia, Brescia, Italy. Electronic address: chiara.lonati@libero.it.
  • Mordasini L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Afferi L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • De Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology-Oncology, Università degli Studi di Milano, Milan, Italy.
  • Di Trapani E; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.
  • Colombo R; Division of Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
  • Briganti A; Division of Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Montorsi F; Division of Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Simeone C; Department of Urology, Spedali Civili di Brescia, Brescia, Italy.
  • Zamboni S; Department of Urology, Spedali Civili di Brescia, Brescia, Italy.
  • Simone G; Department of Urology, "Regina Elena" National Cancer Institute, IRCCS, Rome, Italy.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN.
  • Marra G; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy.
  • Soria F; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy.
  • Gontero P; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical Univ
  • Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; Department of Urology, CHRU Tours, Francois Rabelais University, Tours, France.
  • Hendricksen K; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Ammiwala M; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Poyet C; Department of Urology, University Hospital Zürich, Zürich, Switzerland.
  • Krajewski W; Department of Urology and Oncological Urology, Wroclaw Medical University, Wroclaw, Poland.
  • Baumeister P; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Mattei A; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Moschini M; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland; Division of Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
  • Carando R; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland; Clinica Luganese Moncucco, Lugano, Switzerland; Clinica S.Anna, Swiss Medical Group, Sorengo, Switzerland; Clinica Santa Chiara, Locarno, Switzerland.
Urol Oncol ; 40(5): 195.e27-195.e35, 2022 05.
Article em En | MEDLINE | ID: mdl-35236621
ABSTRACT

BACKGROUND:

The preoperative lymph node (LN) staging of bladder cancer (BCa) addresses the subsequent therapeutic strategy and influences patient's prognosis. However, sparce evidence exists regarding the accuracy of conventional cross-sectional imaging, such as computed tomography or magnetic resonance imaging, in correctly detect LN status. We aimed to assess the diagnostic accuracy of conventional cross-sectional imaging in detecting preoperative LN involvement among BCa patients treated with radical cystectomy and pelvic lymph node dissection.

METHODS:

We retrospectively analyzed data of 1,104 patients who underwent preoperative LN staging with computed tomography or magnetic resonance imaging and subsequent radical cystectomy with pelvic lymph node dissection for BCa between 1997 and 2017 at three tertiary referral centers. Patients receiving neoadjuvant chemotherapy were excluded. We assessed the concordance between clinical (cN) and pathological LN (pN) status, defined as the accuracy of imaging in detecting LN involvement using pathological specimen as reference; concordance was expressed according to Cohen's kappa coefficient. Location-based sub-analyses were performed, distinguishing among external iliac, intern iliac, obturator, common iliac, presacral and paraaortic LNs.

RESULTS:

Among 870 cN0 patients, 68.9% were confirmed pN0 at pathological report; while among 234 cN+ patients, 50.5% were found with LN metastases at pathological specimen. Overall, conventional imaging showed slight concordance (64.9%) between cN and pN stages (sensitivity 30%; specificity 84%). At sub-analysis, no agreement between cN and pN status was found in each LN location, with the only exception of common iliac LNs with slight concordance (37.5%). Common iliac LNs achieved the highest sensitivity and positive likelihood ratio (15% and 2.4, respectively) compared to other LN locations.

CONCLUSIONS:

Overall, preoperative cross-sectional imaging exhibited a slight concordance between cN and pN status. Our location-based sub-analyses showed unsatisfactory results in each LN location- Thus, nomograms combining morphological patterns with serological and clinicopathological features are urgently required.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Neoplasias da Bexiga Urinária Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Neoplasias da Bexiga Urinária Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article